In this context, gene expression analysis from The Cancer Genome Atlas (TCGA) datasets showed reduced expression of DNAM1 and overexpression of its ligand PVR in different tumor types (Figure 4D and Figure S3B) (Table S1). This evidence concerns the gene CD226 and neoplasm.